Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
For sufferers with most cancers who're receiving therapy with radiation remedy, maintaining traces of communication open with their care group concerning potential...
Alecensa (alectinib) demonstrated a 22% discount within the danger of demise in contrast with Xalkori (crizotinib) within the frontline setting of sufferers...
The U.S. Meals and Drug Administration (FDA) has granted uncommon pediatric drug designation for iopofosine-131 in inoperable relapsed or refractory pediatric high-grade...
